Compugroup Medical (Germany) Today
Compugroup Medical is trading at 22.30 as of the 19th of July 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 22.3. The performance scores are derived for the period starting the 20th of April 2025 and ending today, the 19th of July 2025. Click here to learn more.
Valuation
Check how we calculate scores
Compugroup Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Compugroup Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Compugroup Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Drugs, Health Information Services, Technology (View all Sectors) |
Compugroup Medical SE (COP) is traded on Frankfurt Exchange in Germany and employs 8,833 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.34 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Compugroup Medical's market, we take the total number of its shares issued and multiply it by Compugroup Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Compugroup Medical classifies itself under Technology sector and is part of Health Information Services industry. The entity has 52.23 M outstanding shares.
Compugroup Medical SE has accumulated about 44.29 M in cash with 165.27 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.91.
Check Compugroup Medical Probability Of Bankruptcy
Compugroup Medical Risk Profiles
Although Compugroup Medical's alpha and beta are two of the key measurements used to evaluate Compugroup Medical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.502 | |||
| Semi Deviation | 0.6488 | |||
| Standard Deviation | 0.9296 | |||
| Variance | 0.8641 |
Compugroup Stock Against Markets
Compugroup Medical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Compugroup Medical stock to make a market-neutral strategy. Peer analysis of Compugroup Medical could also be used in its relative valuation, which is a method of valuing Compugroup Medical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Compugroup Medical Corporate Management
Elected by the shareholders, the Compugroup Medical's board of directors comprises two types of representatives: Compugroup Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Compugroup. The board's role is to monitor Compugroup Medical's management team and ensure that shareholders' interests are well served. Compugroup Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Compugroup Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Helge Wei | VP Connectivity | Profile | |
| Angela Teufer | Connectivity DACH | Profile | |
| Hannes Reichl | MD Board | Profile | |
| Alexander Weimer | Head Communications | Profile | |
| Michael Franz | Co Communication | Profile | |
| Oliver Bruzek | Chief Affairs | Profile | |
| MBA LLM | MD CFO | Profile |
Other Information on Investing in Compugroup Stock
Compugroup Medical financial ratios help investors to determine whether Compugroup Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Compugroup with respect to the benefits of owning Compugroup Medical security.